by Julian Gikov, Konstantin Ivanov, Octavian Goga, Helena Simicevic, Raiffeisen Bank International Growth on the mergers and acquisitions (M&A) market in Southeast Europe (SEE) continued to accelerate in 2017 and 2018. M&A activity in most SEE countries was influenced by … Read more
The pharmaceutical industry in the SEE region is continuing to show growth contrary to the general trend in Europe, bolstering the notion that it is one of the most resilient sectors. Read more
The global financial downturn and the ongoing European sovereign debt crisis have afflicted almost all industries and the pharmaceuticals sector is no exception. Pharmaceutical companies manufacturing brand drugs face a tough market while companies making generic medicines, or cheaper copies of branded drugs with their patent expired or under an agreement with the branded drug maker, may benefit from the situation.
The coupling of the crisis with the boom in patent expirations continues to give a strong boost to generic drug makers. Read more